Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard

Boston Scientific ( BSX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.5%. By the end of trading, Boston Scientific fell $0.22 (-2.4%) to $9.15 on average volume. Throughout the day, 18,762,723 shares of Boston Scientific exchanged hands as compared to its average daily volume of 18,661,800 shares. The stock ranged in price between $9.15-$9.36 after having opened the day at $9.32 as compared to the previous trading day's close of $9.37. Other companies within the Health Services industry that declined today were: Pingtan Marine Enterprise ( PME), down 65.1%, Intuitive Surgical ( ISRG), down 16.1%, Uroplasty ( UPI), down 9.9% and NeoGenomics ( NEO), down 7.0%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $12.5 billion and is part of the health care sector. Shares are up 63.5% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.

On the positive front, China Cord Blood ( CO), up 9.4%, Health Management Associates ( HMA), up 8.3%, Addus Homecare Corporation ( ADUS), up 8.2% and Utah Medical Products ( UTMD), up 6.3% , were all gainers within the health services industry with Thermo Fisher Scientific ( TMO) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Stocks Trade Mixed Amid Progress on U.S.-China Trade; Dow Turns Lower

Micron Spikes After $10 Billion Buyback Plan Caps Bullish Q3 Earnings Forecast

Micron Spikes After $10 Billion Buyback Plan Caps Bullish Q3 Earnings Forecast

J.C. Penney Shares Fall as CEO Marvin Ellison Resigns to Head Lowe's

J.C. Penney Shares Fall as CEO Marvin Ellison Resigns to Head Lowe's

U.S. Crude Oil Hits Fresh 3-Year Highs as Gas Prices March to $3 a Gallon

U.S. Crude Oil Hits Fresh 3-Year Highs as Gas Prices March to $3 a Gallon

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know